AbbVie has submitted a New Drug Application to the FDA for its investigational pan-genotypic regimen of glecaprevir/pibrentasvir for HCV. Eight studies have shown high SVR across all major genotypes in patients and other health conditions.
AbbVie submits NDA for investigationa... - HFI Connect - Hep...
AbbVie submits NDA for investigational regimen for all HCV genotypes
Written by
HFIAdmin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...
Just found out I have Hep B and have red spots all over is that normal.
Hello everyone, I recently went to the doctors for food poisoning and found out I have typhiod and...
